Gain Therapeutics (GANX) Earnings Date & Reports

Gain Therapeutics Inc is a clinical-stage biotechnology company developing novel small-molecule therapeutics to treat diseases across several therapeutic areas, including central nervous system (CNS) disorders, lysosomal storage disorders (LSDs), metabolic disorders, and other diseases that can be targeted through protein degradation, such as oncology... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

GANX is expected to report earnings to rise 6.77% to -13 cents per share on August 06

Gain Therapeutics GANX Stock Earnings Reports

Q2'26

Est.

$-0.14

Q1'26

Beat

by $0.01

Q4'25

Beat

by $0.03

Q3'25

Est.

$-0.15

Q2'25

Missed

by $0.02

The last earnings report on May 11 showed earnings per share of -12 cents, beating the estimate of -14 cents. With 171.27K shares outstanding, the current market capitalization sits at 79.12M.

View a ticker or compare two or three

Compare

GANX

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for GANX